March 2, 2018

Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTA® (daclizumab) for Relapsing Multiple Sclerosis

CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.–(BUSINESS WIRE)–Biogen (Nasdaq:BIIB) and AbbVie (NYSE:ABBV) today announced the voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. The companies believe that characterizing the complex and […]
October 21, 2015

Link Between Low Vitamin D And Multiple Sclerosis – Study

A new research study has linked low vitamin D with increased risk of multiple sclerosis (MS). The study found that four genetic variants carried by individuals […]
October 13, 2015

Can Stem Cells Roll Back the MS Clock?

Rolling back the clock in a multiple sclerosis (MS) patient means getting back some of the lost physical function, cognitive function, and overall quality of life […]
July 29, 2015

MS and Anxiety

If you have multiple sclerosis (MS), its unpredictability can make you anxious. Learn how to control your worries and manage anxiety. More than a third of […]
June 25, 2015

Treatment at the First Sign of Illness Improves MS, Study Says

A long-term study shows treatments with interferon when multiple sclerosis is first suspected — even before a definite diagnosis — can result in less disease activity […]
June 25, 2015

Multiple sclerosis: Scientists ID cause of movement, balance problems

New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty “brake” within immune cells, a brake that should be […]